MINNEAPOLIS , Dec. 22, 2014 /PRNewswire/ -- Inspire Medical Systems, Inc. announced today that Tim Herbert , president and CEO, will present an overview of the company's business at the 33rd Annual J.P. Morgan Healthcare Conference. The presentation is scheduled for 8:00 a.m. PT on Monday, January 12, 2015 , at the Westin St. Francis Hotel in San Francisco .
Inspire Medical Systems developed and markets the first implantable device for obstructive sleep apnea (OSA). Approved by the U.S. Food and Drug Administration (FDA) in April 2014 , Inspire Upper Airway Stimulation (UAS) therapy is an effective new treatment option for those with moderate to severe OSA who are unable or unwilling to use Continuous Positive Airway Pressure (CPAP). Inspire therapy delivers mild stimulation to key airway muscles which keeps the airway open during sleep.
Leading medical centers in the United States and Europe now offer Inspire therapy as part of their sleep apnea treatment programs. In the United States , commercial insurance payers have provided reimbursement for sleep apnea patients who meet the FDA indications for use for Inspire therapy. During the presentation, the company will review its accomplishments in 2014 and layout the business plans for 2015.
About Inspire therapy
About Inspire Medical Systems
To learn more and to locate medical centers offering Inspire therapy, visit Inspire Medical Systems on the web at www.inspiresleep.com .
To view the original version on PR Newswire, visit: http://www.prnewswire.com/news-releases/inspire-medical-systems-to-present-at-33rd-annual-jp-morgan-healthcare-conference-300013286.html
SOURCE Inspire Medical Systems, Inc.